Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

With nearly 50 brands of generic semaglutide set to launch in the Indian market on Saturday, doctors applaud the reduced cost and increased availability of the drug for their patients, along with a ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

Come March 20, when the patent for Semaglutide expires, the Indian market is expected to see the launch of generic drugs from at least seven pharma companies, at costs ranging from one-third to ...

Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...

This nine-digit number identifies your bank or credit union in a financial transaction. This page includes information about these cards, currently unavailable on NerdWallet. The information has been ...

Over the past year, I have been writing a series of articles exploring the evolution of stablecoins and their growing role in global payments infrastructure. Those discussions examined topics ranging ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

A newly-formed Canadian pharmaceutical company is vying to break into the market with a generic version of one of the most well-known prescription drugs in the world: Ozempic. “You could say we’re ...